Home › NDC Lookup › Ingredients › Octinoxate, Octocrylene, Titanium Dioxid... › 67225-5219-03
AGE20S SIGNATURE ESSENCE PACT INTENSE COVER 23W Octinoxate, Octocrylene, Titanium Dioxide .42 g/14g; .7186 g/14g; .91 g/14g Cream — NDC 67225-5219-03 package photo

AGE20S SIGNATURE ESSENCE PACT INTENSE COVER 23W Octinoxate, Octocrylene, Titanium Dioxide .42 g/14g; .7186 g/14g; .91 g/14g Cream

by Aekyung Industrial Co., Ltd. · 2 CASE in 1 BOX (67225-5219-3) / 14 g in 1 CASE (67225-5219-1)
NDC 67225-5219-03
🏷️ FDA NDC (as labeled) 67225-5219-3 billing pads the package segment with a zero
This package
Contains14 g in 1 case Pack sizes2 compare ↓
Also comes in: 14 g 67225-5219-02
OTC On market Non-controlled
🗂️ Data synced Aug 27, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 67225-5219-3
Product NDC 67225-5219
11-digit billing NDC 67225521903
UNII 5A68WGF6WM, 15FIX9V2JP, 4Y5P7MUD51
Application # M020
SPL Set ID 37d4d8c1-e76b-48a3-9a13-f0543af1b28f
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2025-08-13
Route TOPICAL
Dosage form CREAM
Substance OCTOCRYLENE; TITANIUM DIOXIDE; OCTINOXATE
Why two NDCs? The FDA registers this code as 67225-5219-3 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 67225-5219-03. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏭 Manufacturer & labeler

LabelerAekyung Industrial Co., Ltd.
FDA applicationM020 (OTC MONOGRAPH DRUG)
Labeler code67225
First marketedAug 2025
Product typeHuman Otc Drug
Portfolio64 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

🧪 What is this product?

This is a topical cream product marketed as an OTC monograph sunscreen. The active ingredients are octinoxate and octocrylene, which are ultraviolet (UV) filters that function to absorb UV rays, and titanium dioxide, a mineral UV filter that works by reflecting and scattering UV light. Products containing these ingredients are typically used as cosmetic sunscreen preparations applied to the skin to help protect against sun exposure. This listing reflects a formula governed by FDA's over-the-counter monograph rules for sunscreen products.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 14 g
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Age20S Signature Essence Pact Intense Cover 21W .42 g/14g; .7186 g/14g; .91 g/14g 67225-5202-02 Aekyung 14 g — — FDA listed —
Age20S Signature Essence Pact Intense Cover 31N .42 g/14g; .7186 g/14g; .91 g/14g 67225-5214-02 Aekyung 14 g — — FDA listed —
Age20S Signature Essence Pact Intense Cover 25N .42 g/14g; .7186 g/14g; .91 g/14g 67225-5217-02 Aekyung 14 g — — FDA listed —
Age20S Signature Essence Pact Intense Cover 41N .42 g/14g; .7186 g/14g; .91 g/14g 67225-5209-02 Aekyung 14 g — — FDA listed —
Age20S Signature Essence Pact Intense Cover 19C .42 g/14g; .7186 g/14g; .91 g/14g 67225-5220-02 Aekyung 14 g — — FDA listed —
Age20S Signature Essence Pact Intense Cover 15C .42 g/14g; .7186 g/14g; .91 g/14g 67225-5203-02 Aekyung 14 g — — FDA listed —
Age20S Signature Essence Pact Intense Cover 29W .42 g/14g; .7186 g/14g; .91 g/14g 67225-5208-02 Aekyung 14 g — — FDA listed —
Age20S Signature Essence Pact Intense Cover 35N .42 g/14g; .7186 g/14g; .91 g/14g 67225-5210-02 Aekyung 14 g — — FDA listed —
Age20S Signature Essence Pact Intense Cover 23W .42 g/14g; .7186 g/14g; .91 g/14gthis 67225-5219-03 Aekyung 14 g — — FDA listed —
Age20S Signature Essence Pact Intense Cover 13C .42 g/14g; .7186 g/14g; .91 g/14g 67225-5221-02 Aekyung 14 g — — FDA listed —
Age20S Signature Essence Pact Intense Cover 47N .42 g/14g; .7186 g/14g; .91 g/14g 67225-5212-02 Aekyung 14 g — — FDA listed —
Age20S Signature Essence Pact Intense Cover 33W .42 g/14g; .7186 g/14g; .91 g/14g 67225-5213-02 Aekyung 14 g — — FDA listed —
Age20S Signature Essence Pact Intense Cover 27W .42 g/14g; .7186 g/14g; .91 g/14g 67225-5215-02 Aekyung 14 g — — FDA listed —
Age20S Signature Essence Pact Intense Cover 27C .42 g/14g; .7186 g/14g; .91 g/14g 67225-5205-02 Aekyung 14 g — — FDA listed —
Age20S Signature Essence Pact Intense Cover 24W .42 g/14g; .7186 g/14g; .91 g/14g 67225-5204-02 Aekyung 14 g — — FDA listed —
Age20S Signature Essence Pact Intense Cover 29C .42 g/14g; .7186 g/14g; .91 g/14g 67225-5216-02 Aekyung 14 g — — FDA listed —
Age20S Signature Essence Pact Intense Cover 28N .42 g/14g; .7186 g/14g; .91 g/14g 67225-5206-02 Aekyung 14 g — — FDA listed —
Age20S Signature Essence Pact Intense Cover 33N .42 g/14g; .7186 g/14g; .91 g/14g 67225-5207-02 Aekyung 14 g — — FDA listed —
Age20S Signature Essence Pact Intense Cover 21N .42 g/14g; .7186 g/14g; .91 g/14g 67225-5218-02 Aekyung 14 g — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2025
On the market since
Aug 2025
📍
2026
Currently FDA-listed
1 year listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
67225-5219-02 1 CASE in 1 PACKAGE (67225-5219-2) / 14 g in 1 CASE (67225-5219-1) 2025-08-13 Active
67225-5219-03 You're viewing this 2 CASE in 1 BOX (67225-5219-3) / 14 g in 1 CASE (67225-5219-1) 2026-01-21 Active

Pack size FAQ

What quantity is in NDC 67225-5219-03?
NDC 67225-5219-03 is listed by the FDA — 2 case in 1 box / 14 g in 1 case.
What NDC number is used to bill for this package of AGE20S SIGNATURE ESSENCE PACT INTENSE COVER 23W Octinoxate, Octocrylene, Titanium Dioxide .42 g/14g; .7186 g/14g; .91 g/14g Cream?
Bill NDC 67225-5219-03 — the 11-digit billing format is 67225521903. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 67225-5219-3, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 67225-5219-03, written without dashes as 67225521903. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 67225-5219-03, the first segment (67225) is the labeler code FDA assigned to Aekyung Industrial Co., Ltd.; the middle segment (5219) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (03) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Aekyung Industrial Co., Ltd.. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 14 g (67225-5219-02). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Aekyung Industrial Co., Ltd. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 30 words ▾

■ Helps prevent sunburn. ■ If used as directed with other sun protection measures (See Directions), decreases the risk of skin cancer and early skin aging caused by the sun.

⏱️ Dosage and Administration 98 words ▾

Directions ■ Apply liberally 15 minutes before sun exposure. ■ Children under 6 months of age: Ask a doctor. ■ Reapply at least every 2 hours. ■ Use a water-resistant sunscreen if swimming or sweating ■ Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. Todecrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: ■ Limit time in the sun, especially from 10 a.m. - 2 p.m. ■ Wear long-sleeved shirts, pants, hats, and sunglasses.

⚠️ Warnings 4 words ▾

For external use only

🧪 Active Ingredient 7 words ▾

Octinoxate 6.50% Octocrylene 3.00% Titanium Dioxide 5.12%

🧪 Inactive Ingredients 126 words ▾

WATER (AQUA), ETHYLHEXYL METHOXYCINNAMATE, TITANIUM DIOXIDE (NANO), BETULA PLATYPHYLLA JAPONICA JUICE, DIPROPYLENE GLYCOL PENTAERYTHRITYL STEARATE/CAPRATE/CAPRYLATE/ADIPATE, HYDROGENATED POLY(C6-14 OLEFIN), OCTOCRYLENE, PHENYL TRIMETHICONE NIACINAMIDE, EUPHORBIA CERIFERA (CANDELILLA) WAX, DIMETHICONE, BUTYLENE GLYCOL, ALOE BARBADENSIS LEAF EXTRACT, TRIISOSTEARIN, 1,2-HEXANEDIOL, DISODODECANE, POLYMETHYLSILSESQUIOXANE, ISODECYL NEOPENTANOATE, PROPANEDIOL, VP/HEXADECENE COPOLYMER, ALUMINUM HYDROXIDE, CETYL PEG/PPG-10/1 DIMETHICONE, SODIUM GLUTAMATE, C30-45 ALKYL METHICONE, STEARIC ACID, P-ANISIC ACID, DIMETHICONE/PEG-10/15 CROSSPOLYMER, C30-45 OLEFIN, GLYCERYL CAPRYLATE, BETULA PLATYPHYLLA JAPONICA BARK EXTRACT, GLYCERIN, TRIETHOXYCAPRYLYLSILANE, PANTHENOL, TOCOPHERYL ACETATE, CERAMIDE NP, METHYL METHACRYLATE CROSSPOLYMER, STEARYL HEPTANOATE, ADENOSINE, SILICA, HYDROLYZED HYALURONIC ACID, POLYHYDROXYSTEARIC ACID, SODIUM HYALURONATE, LACTOBACILLUS FERMENT LYSATE, HAEMATOCOCCUS PLUVIALIS EXTRACT, LINOLEIC ACID, BHT, SODIUM CITRATE, BORON NITRIDE, ASTAXANTHIN, PENTAERYTHRITYL TETRA-DI-T-BUTYL, YDROXYHYDROCINNAMATE, TOCOPHEROL, APHANOTHECE SACRUM POLYSACCHARIDE, FRAGRANCE (PARFUM), Titanium Dioxide(CI 77891), IRON OXIDES (CI 77492), IRON OXIDES (CI 77491), IRON OXIDES (CI 77499)

🎯 Purpose 1 words ▾

Sunscreen

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 67225-5218-02 · Aekyung 67225-5220-02 · Aekyung →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.